MarketInOut Stock Screener Log In | Sign Up

AbbVie Inc

IEX • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeIEX
Market Capitalization521,105 mln
Float1,765 mln
Earnings Date10/30/2026

EPS

3.54
Stretched

P / E

83.26
Speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.86
Likely reliable

1-Year Forecast

283.19
Fairly priced

Relative Strength

75 / 100
Strongly outperforming

Business Description

AbbVie is a global pharmaceutical company founded in 2012 and based in North Chicago, Illinois, that develops and sells treatments across a wide range of medical conditions. Its portfolio includes medicines for blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, and eye conditions, as well as therapies for hepatitis C and digestive health. The company also has a strong presence in aesthetics, offering products such as Botox and the Juvederm collection for cosmetic and skin-related treatments.

Key Fundamentals

EPS3.54
P/E83.26
ROE-224
RPS37.32
ROIC14.21
ROA4.66
Interest Cover7.13
EBITDA, mln19,694
EV / EBITDA29.78
EV / EBIT49.76
Revenue, mln64,386
EV / Revenue9.11

Quote Details

Last 294.89
Change 3.95 (1.36%)
Open 292.00
Volume 4,248,871
Turnover 1,252,949,632
Average Volume 3,471,236

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio0.81
Price / Cash Flow26.79
Price / Free Cash Flow28.71
Price / Sales8.12
PEG Ratio0.59

Financial Strength

Altman Z-Score2.73
Piotroski F-Score 8 / 9
Beneish M-Score-2.86
Price to Intrinsic Value2.89
1-Year Target Price283.19
Shiller PE Ratio61.22
Short Ratio3.22
Short % of Float0.98

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.24% 82 / 100   
1 Month 14.13% 93 / 100   
2 Months 15.47% 89 / 100   
6 Months 44.61% 95 / 100   
1 Year 34.83% 79 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog